Table 1 Patient characteristics
Characteristic | PBMS group | Control group | p |
|---|---|---|---|
Patients, n | 82 | 82 | Â |
Age,years (s.d.) | 53.7 (8.9) | 53.8 (7.9) | 0.91 |
Height,cm (s.d.) | 159 (4.6) | 160.4 (5.3) | 0.07 |
Weight,kg (s.d.) | 61.6 (8.1) | 62.0 (8.3) | 0.55 |
Body mass index, kg/m2 (s.d.) | 24.4 (2.4) | 24.1 (3.0) | 0.74 |
Pathology, n (%) | Â | Â | 0.72 |
 Squamous cell carcinoma | 79 (96.3) | 77 (93.9) |  |
 Adenocarcinoma | 3 (3.7) | 5 (6.1) |  |
Clinical stage, n (%) | Â | Â | 0.83 |
 Ib2 | 2 (2.4) | 4 (4.9) |  |
 IIa1 | 3 (3.7) | 2 (2.4) |  |
 IIa2 | 2 (2.4) | 3 (3.7) |  |
 IIb | 29 (35.4) | 32 (39.0) |  |
 IIIb | 46 (56.1) | 41 (50.0) |  |
ECOG, n (%) | Â | Â | 0.82 |
 1 | 71 (86.6) | 72 (87.8) |  |
 2 | 11 (13.4) | 10 (12.2) |  |
Original routine blood test (s.d.) | |||
 WBC,*10^9/L | 7.0 (2.4) | 7.0 (3.2) | 0.94 |
 ANC,*10^9/L | 4.8 (2.3) | 4.7 (2.8) | 0.87 |
 HGB, g/L | 127.8 (14.2) | 125.4 (17.8) | 0.27 |
 PLT,*10^9/L | 268.1 (60.3) | 269.3 (81.4) | 0.85 |
 Comorbidity, n(%) | 18 (22.0) | 22 (26.8) | 0.47 |